CXCR4 and RANK Combination as a Predictor of Breast Cancer Bone Metastasis in Indonesia
Open Access
- 10 February 2021
- journal article
- Published by Peertechz Publications Private Limited in Journal of Surgery and Surgical Research
- Vol. 7 (1), 020-025
- https://doi.org/10.17352/2455-2968.000130
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Identification of PTHrP(12-48) as a Plasma Biomarker Associated with Breast Cancer Bone MetastasisCancer Epidemiology, Biomarkers & Prevention, 2013
- Bone metastasis in breast cancer: The story of RANK-LigandJournal of the Egyptian National Cancer Institute, 2012
- RANK, RANKL and OPG Expression in Breast Cancer – Influence on Osseous MetastasisGeburtshilfe und Frauenheilkunde, 2012
- Role of RANK, RANKL, OPG, and CXCR4 Tissue Markers in Predicting Bone Metastases in Breast Cancer PatientsClinical Breast Cancer, 2011
- The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot StudyOncology, 2011
- Optimal management of bone metastases in breast cancer patientsBreast Cancer: Targets and Therapy, 2011
- Integrins and bone metastasis: Integrating tumor cell and stromal cell interactionsBone, 2011
- CSLEX (Sialyl Lewis X) is a Useful Tumor Marker for Monitoring of Breast Cancer PatientsJapanese Journal of Clinical Oncology, 2010
- Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosisJournal of Experimental & Clinical Cancer Research, 2010
- Economic burden of metastatic bone disease in the U.S.Cancer, 2007